Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.31 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27689847 | 0.91 | SLC7A5 (0.37) | SLC7A5TP53LTA4HSLC1A3SLC1A2 | |
| SCHEMBL28762244 | 0.91 | SLC7A5 (0.37) | SLC7A5TP53LTA4HSLC1A3SLC1A2 | |
| SCHEMBL1171991 | 0.89 | SLC7A5 (0.36) | SLC7A5TP53 | |
| SCHEMBL27280094 | 0.83 | SLC1A3 (0.32) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL27280095 | 0.83 | SLC1A3 (0.32) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL7439793 | 0.79 | ALDH1A1 (0.31) | — | |
| SCHEMBL1852419 | 0.78 | SLC7A5 (0.39) | SLC7A5TP53LTA4HSLC1A3SLC1A2 | |
| SCHEMBL15390916 | 0.78 | SLC7A5 (0.39) | SLC7A5TP53LTA4HSLC1A3SLC1A2 | |
| SCHEMBL17100558 | 0.76 | SLC7A5 (0.37) | SLC7A5TP53LTA4HSLC1A3SLC1A2 | |
| Ammonia Solution, Strong SCHEMBL27846030 | 0.75 | SLC7A5 (0.36) | SLC7A5TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070269832-A1 | Novel affinity labels | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070269832-A1 | Novel affinity labels | ANPEP, SLC7A1, DNPEP | SLC7A5 46/4885TP53 1021/4885LTA4H 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.